Nanjing Sinolife United Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001S08
HKD
0.38
0.02 (5.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Zhongzhi Pharmaceutical Holdings Ltd.
China Shineway Pharmaceutical Group Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd.
Nanjing Sinolife United Co., Ltd.
HBM Holdings Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
China Health Group, Inc.
Hin Sang Group (International) Holding Co. Ltd.
PuraPharm Corp. Ltd.
Wai Yuen Tong Medicine Holdings Ltd.
Why is Nanjing Sinolife United Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 4.58%
  • Poor long term growth as Net Sales has grown by an annual rate of 17.80% and Operating profit at 16.63% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.08
2
Flat results in Dec 24
  • PRE-TAX PROFIT(Q) Fallen at -98.05%
  • NET PROFIT(Q) Fallen at -95.33%
3
With ROE of 8.93%, it has a Expensive valuation with a 0.90 Price to Book Value
  • Over the past year, while the stock has generated a return of -34.48%, its profits have fallen by -35.7%
4
Underperformed the market in the last 1 year
  • Even though the market (Hang Seng Hong Kong) has generated returns of 26.67% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -34.48% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Sinolife United Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nanjing Sinolife United Co., Ltd.
-36.67%
-0.31
73.17%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.80%
EBIT Growth (5y)
16.63%
EBIT to Interest (avg)
-12.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
1.17
Tax Ratio
15.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.21%
ROE (avg)
4.58%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.90
EV to EBIT
6.11
EV to EBITDA
4.53
EV to Capital Employed
0.87
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.22%
ROE (Latest)
8.93%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Nanjing Sinolife United Co., Ltd.
Operating Cash Flow
Highest at HKD 45.65 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Net Sales
Highest at HKD 409.74 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (HKD MM)

Debtors Turnover Ratio
Highest at 17.58%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -24.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 7.93 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Nanjing Sinolife United Co., Ltd.
Pre-Tax Profit
Fallen at -98.05%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Fallen at -95.33%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)